Euretina Logo, Links to homepage.
Euretina Logo, Links to homepage.
  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Registration
      • Poster Submission
      • Programme
    • Euretina 2026 Vienna
      • On-Demand
      • Congress Daily
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • Euretina Innovation Spotlight (EIS) 2026
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Mentorship Programme
      • Mentorship Alumni
    • Ramin Tadayoni Award
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Registration
      • Poster Submission
      • Programme
    • Euretina 2026 Vienna
      • On-Demand
      • Congress Daily
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • Euretina Innovation Spotlight (EIS) 2026
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Mentorship Programme
      • Mentorship Alumni
    • Ramin Tadayoni Award
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • September 10, 2021
  • 2021 Abstracts

Real-life implementation of smartphone-based home vision monitoring in a high volume intravitreal injection service for patients with neovascular Age-related Macular Degeneration and Retinal Vascular Disease

Author: Konstantinos Balaskas (United Kingdom)

Co-authors: Nikolas Pontikos, Eddie Korot, Aljazy Jaber, Peter Thomas, Dawn Sim, Pearse Keane

Purpose

A patient-centric approach to modern eye care involves not only bringing care to patients’ homes, but ideally to the palm of their hands. Smartphone-based apps have been developed that allow self-testing of visual function by patients at home. These technologies could contribute to de-centralisation of care for patients with medical retina disease by reducing the number of hospital visits. Potential applications of home vision monitoring include early detection of progression from intermediate to neovascular Age-related Macular Degeneration (nAMD), fellow eye conversion in patients with nAMD in the first eye as well as monitoring of patients receiving anti-vascular endothelial growth factor (anti-VEGF) treatment for nAMD, Diabetic Macular Oedema (DMO) or macular oedema secondary to Retinal Vein Occlusions (RVO). A significant consideration for real-life deployment of home vision monitoring technologies is assessing their uptake and usability by patients and addressing issues around digital exclusion, particularly in an elderly patient population such as patients with nAMD.

Setting/Venue

This service improvement project was conducted in the high volume intravitreal treatment service of Moorfields Eye Hospital, London, UK - a major tertiary care ophthalmology centre. Patients receiving anti-VEGF treatment for nAMD, DMO or RVOs were prescribed a smartphone-based app (Home Vision Monitor, HVM) linked with a web-based data store and associated portal for review of vision testing results by prescribing clinicians. The HVM app has received FDA 510k clearance (myVisionTrack, Vital Art and Scence, Richardson, USA) and uses shape discrimination tasks to detect metamorphopsia in the central degrees of vision as a metric of visual function.

Methods

Consecutive patients attending Moorfields Eye Hospital for planned anti-VEGF treatment between May 2020 and February 2021 were offered the HVM smartphone app and advised to self-test their vision at least twice a week. A unique link is established between each patient and the prescribing clinician through a registration code. Vision test results (HVM scores) are reviewed by the prescribing clinician on the on-line portal. A change in visual function equivalent to 0.2 on the LogMAR scale triggers an alert and notification message to the clinical team. A patient survey was conducted for a sub-set of patients using the HVM app to assess patient experience and perceptions as well as capture patient characteristics that could influence uptake and engagement. Data from the HVM portal (frequency of use), the Electronic Health Record (demographic and clinical data) and the patient surveys were used to inform an analysis of parameters influencing uptake (defined as successful installation and use of the app at least on one occasion) and engagement/compliance (defined as any continuous period of 4 weeks with use of the app more than once per week) for participating patients. Analysis was performed as part of a registered Moorfields Eye Hospital service improvement audit.

Results

418 patients were included in analysis of factors influencing uptake and engagement for home-vision monitoring. Of those, 258 patients were active users and 160 non-active (uptake assessment). Of active patients with adequate length of follow-up to determine engagement, 166 patients fulfilled the definition of compliance and 92 did not. 114 active patients completed the patient survey. Uptake was significantly associated with age (every 5 years of older age reduced uptake by 5%, p=0.031), biological sex (female users 1.4 times higher uptake than male users, p=0.036) and positively associated with visual acuity in the better seeing eye (p=0.014) and number of intravitreal injections (p= 0.039). Engagement/compliance was significantly associated with diagnosis (nAMD patients were more compliant than patients with DMO or RVO, p=0.003) and was positively associated with white British ethnicity (p=0.025) and visual acuity in the better seeing eye (p=0.007). In the group that completed the patient experience survey, engagement was higher in patients who reported English as their first language (p=0.006) and had a borderline association with higher satisfaction with app use (p=0.06).After adjusting for age, biological sex and diagnosis,​​ engagement was associated with patients' level of comfort with digital technologies and visual ​acuity in the worse seeing eye.

Conlusions

Home vision monitoring with smartphone-based apps has potential meaningful applications for the care of patients with common medical retina disease. The expected benefits from their deployment in real-life clinical practice pertain to early disease detection, personalised re-treatment intervals, reduction of unnecessary hospital visits and patient empowerment for self-care. Before assessing the potential benefits of home vision monitoring, it is crucial to consider the feasibility of wide-spread real-life deployment of such digital tools for self-care. Uptake and usability of self-monitoring technologies are crucial determinants for their meaningful real-life deployment at scale. In this work, we examined the uptake and engagement with home vision monitoring of patients attending a busy injection clinic for treatment of common retinal conditions. This is the first report of real-life deployment of home-vision monitoring at scale in this patient population. A number of demographic, clinical, socioeconomic and patient perception-related factors were shown to affect uptake and compliance of patients with the use of the prescribed smartphone-based app. As healthcare systems increasingly adopt digital models of care, issues such as digital exclusion require careful consideration to ensure equitable access to high quality care for every patient.

Financial Disclosure

Roche provided funding for the service improvement initiative involving the introduction of home-vision monitoring for the care of patients receiving intravitreal injections at Moorfields Eye Hospital, City Road.

Comments

-
PrevPrevious
NextNext
Euretina Logo, Links to homepage.

European Society of Retina Specialists c/o Congrex Switzerland
Reinacherstrasse 131
4053 Basel
Switzerland

T +41 61 686 77 91
F +41 61 686 77 88

General Enquires: [email protected]

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 
 
 

Follow us

© EURETINA 2026 All rights reserved

  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Registration
      • Poster Submission
      • Programme
    • Euretina 2026 Vienna
      • On-Demand
      • Congress Daily
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • Euretina Innovation Spotlight (EIS) 2026
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Mentorship Programme
      • Mentorship Alumni
    • Ramin Tadayoni Award
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login